These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23428698)

  • 21. Psychiatric medication-induced obesity: a review.
    Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
    Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.
    Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE
    Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of antidepressants and antipsychotics on weight gain in children and adolescents.
    Reekie J; Hosking SP; Prakash C; Kao KT; Juonala M; Sabin MA
    Obes Rev; 2015 Jul; 16(7):566-80. PubMed ID: 26016407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics.
    Stein K
    J Am Diet Assoc; 2010 Jul; 110(7):992-1001. PubMed ID: 20630154
    [No Abstract]   [Full Text] [Related]  

  • 26. The efficacy, safety, and tolerability of antipsychotics in the elderly.
    Maixner SM; Mellow AM; Tandon R
    J Clin Psychiatry; 1999; 60 Suppl 8():29-41. PubMed ID: 10335669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychiatric medication-induced obesity: treatment options.
    Schwartz TL; Nihalani N; Virk S; Jindal S; Chilton M
    Obes Rev; 2004 Nov; 5(4):233-8. PubMed ID: 15458397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction. Weight gain with psychotropics: size does matter.
    Masand PS
    J Clin Psychiatry; 1999; 60 Suppl 21():3-4. PubMed ID: 10548134
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antidepressants, antipsychotics and metabolic risks].
    Wittmann M; Hübner-Liebermann B; Wenzel-Seifert K; Hausner H
    MMW Fortschr Med; 2011 Mar; 153(9):42-4. PubMed ID: 21638864
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs for psychiatric disorders.
    Treat Guidel Med Lett; 2013 Jun; 11(130):53-64; quiz 2p following 64. PubMed ID: 23715100
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationships among psychiatric medications, eating behaviors, and weight.
    Davison KM
    Eat Behav; 2013 Apr; 14(2):187-91. PubMed ID: 23557818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacologic treatment of eating disorders.
    Walsh BT; Devlin MJ
    Psychiatr Clin North Am; 1992 Mar; 15(1):149-60. PubMed ID: 1347938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
    Gitlin MJ
    CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929
    [No Abstract]   [Full Text] [Related]  

  • 37. Drugs and depression.
    Harris B
    Am J Nurs; 1986 Mar; 86(3):292-3. PubMed ID: 2869688
    [No Abstract]   [Full Text] [Related]  

  • 38. Antidepressants and body weight: a comprehensive review and meta-analysis.
    Serretti A; Mandelli L
    J Clin Psychiatry; 2010 Oct; 71(10):1259-72. PubMed ID: 21062615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychopharmacology in a genomic perspective].
    Werge T; Kessing LV
    Ugeskr Laeger; 2005 May; 167(20):2194-6. PubMed ID: 15987083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.